BIOTECH · DOES IT FIT US?

Your GxP scope grows.
Quality work keeps pace — evidenced, reviewable, decided.

traqx prepares SOP updates, validation evidence and GxP handovers inside the scope your team defines — with source, status and open points kept on the work object. What counts as GxP-relevant stays your team's call; review and release remain with your experts.

Book your personal live demo →

No obligation · personal · straight in the calendar

View traqx →

WHAT YOUR TEAM GAINS

A growing GxP scope means more obligations — not necessarily more friction.

New processes start structured
Transfers, systems and handovers begin in the source space your team defines.
Evidence with source and status
Drafts and documentation arrive with source, status and open points on the work object.
Your team keeps the GxP decision
Your team decides what is GxP-relevant; review and release stay with your experts.

THREE CONCRETE SITUATIONS

How traqx prepares groundwork in biotech quality work.

Each situation stays in your team's scope: controlled inputs, a reviewable result, no blanket GxP classification of research.

Compliance Agent · product view in traqx

01Frame requirements for transferring a biological manufacturing process

CONTROLLED INPUTSDefined transfer work package, process description, approved site policies, selected external requirements and a documented scope assumption.

WHAT TRAQX DOESCompliance Agent · Maps statements to the approved sources, marks missing evidence and open scope questions.

REVIEWABLE RESULTEvidenced statements, a gap list and openly flagged scope questions.

WHAT YOUR TEAM DECIDESYour team decides which requirements apply to the transfer work package; traqx does not classify the GxP scope autonomously.

02Move a development instruction into a defined GxP-relevant operating step

CONTROLLED INPUTSExisting development or work instruction, the team-defined move into GxP operations, approved policy and current template.

WHAT TRAQX DOESSOP Agent · Prepares a source-bound, traceable revision for the new process boundary.

REVIEWABLE RESULTWord file with tracked changes, source and rationale comments, and an updated version history.

WHAT YOUR TEAM DECIDESYour experts define scope and transition and own review and release; traqx does not pull research into GxP scope itself.

03Document newly added equipment or a computer system in the defined scope

CONTROLLED INPUTSEquipment or computer system in the defined GxP scope, approved intended use, system description, interfaces, commissioning risk assumptions.

WHAT TRAQX DOESValidation Agent · Prepares requirements, risks, tests and potential traces from the controlled foundations.

REVIEWABLE RESULTDraft requirements and risks, test and traceability candidates, and clearly marked gaps.

WHAT YOUR TEAM DECIDESThe validation expert assesses and decides; early research outside the defined scope remains untouched.

The actual GxP process bounds sources, method and review — the industry label alone is not enough.

01SCOPEBound the GxP-relevant work object
The team decides which processes, sources and internal requirements genuinely belong in scope.
Result · deliberate scope boundary
02GENERATEPrepare research, draft and update
traqx works inside the defined source room and creates reviewable suggestions — no open-web context.
Result · bounded groundwork
03VERIFYKeep source, status and open points visible
Evidence and gaps stay on the work object; unsupported points are not treated as finished decisions.
Result · reviewable work state
04REVIEWLet subject-matter experts review and decide
Quality and functional experts correct, accept or reject; your approval path stays accountable.
Result · human decision

FIT / BOUNDARY

A fit for GxP-relevant quality work. Not automatically for all biotech work.

The organization defines the real process and regulatory context; traqx does not infer it from the industry.

✓ FITS

Controlled SOP, validation and evidence work

A concrete GxP process is defined, relevant sources can be bounded and experts remain accountable for review and decision.

— DOES NOT FIT AS

Drug discovery, laboratory informatics or research decision

traqx is neither a scientific decision platform nor a LIMS here, and it does not turn exploratory research into blanket GxP work.

EVIDENCE, NOT A MARKETING CLAIM

Inspect the working model without a biotech-specific promise.

traqx is EU-hosted and works in controlled source rooms; customer documents stay within the agreed tenant and hosting scope and are not used for model training. Experts review and decide. The product dossiers show real system views with synthetic demo data—not biotech customer outcomes.

View practice case & product dossiers →Trust System →

VISIBLE PRIMARY SOURCES

GMP sources apply only when GMP manufacturing is actually in scope.

European Commission · EudraLex Volume 4
The official collection of EU GMP guidelines is relevant when the concrete biotech process falls within a GMP manufacturing context. The industry label alone does not establish that link.
EU GMP Chapter 4 · Documentation
Chapter 4 frames documentation inside the GMP context. The source is not extended here to exploratory research or scientific decision work.

FAQ

Biotech fit starts with the scope question.

Is traqx a fit for a biotech quality team—and does the work need to be GxP-relevant?

traqx fits a biotech quality team when the concrete work object is genuinely GxP-relevant and controlled sources are needed for SOP, validation, qualification or audit groundwork. Not every biotech activity is GxP; exploratory research, drug discovery and scientific decisions are not the product fit described here.

Who decides whether a biotech work object is GxP-relevant?

The customer frames the actual process against the applicable regulatory and internal context. traqx supports controlled work inside the defined scope but makes no legal or subject-matter GxP classification.

How does traqx prevent research documents from entering GxP scope without review?

The team defines the work object, process boundary and approved sources in advance. traqx works only inside that controlled scope and identifies open scope questions instead of classifying research as GxP-relevant itself.

Is traqx a drug-discovery or laboratory platform?

No. This page promises neither drug-discovery functions nor laboratory informatics or scientific decision support. The fit is controlled quality and document work inside the actual GxP scope.

Your GxP scope grows.Quality work keeps pace — evidenced, reviewable, decided.

A growing GxP scope means more obligations — not necessarily more friction.

How traqx prepares groundwork in biotech quality work.

Mapped traqx use cases for this industry.

SOP management

CSV / CSA

Audit readiness

Change Control

CAPA

Equipment qualification

Process validation / CPV

Supplier Assessment

IT infrastructure qualification

Cleanroom / Annex 1

Define the scope first. Then prepare controlled groundwork.